Colorectal Cancer Forecast in 18 Major Markets 2017-2027: Overview of the Risk Factors, Disease Diagnosis and Prognosis with Specific Variations - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Colorectal Cancer Forecast in 18 Major Markets 2017-2027" report to their offering.

This report provides the current incident population for Colorectal Cancer across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, India, China, Turkey, Mexico, Russia, Argentina, Australia, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Colorectal Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Colorectal Cancer include:

- Change in bowel habits, including diarrhea or constipation or a change in the consistency of stools

- Rectal bleeding or blood in the stool

- Persistent abdominal discomfort, such as cramps, gas or pain

- A feeling that the bowel doesn't empty completely

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line incidence for Colorectal Cancer

10. Staging of Colorectal Cancer patients

11. Genetic mutations in Colorectal Cancer patients

12. Treatment of Colorectal Cancer patients

13. Abbreviations used in the report

14. Patient-Based Offering

15. Online Pricing Data and Platforms

16. References

17. Appendix

List of Figures

For more information about this report visit http://www.researchandmarkets.com/research/53fvmf/colorectal_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Colon Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Colon Cancer Drugs